| Intrinsic Valuation of: NTRA | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | -2 | Market Cap | $27B | |||||
| 2021 | - | - (-) | P/E Ratio | - | Total Asset | $2B | |||||
| 2022 | $-479M | - (-) | Net Income | $-208M | Total Debt | $0 | |||||
| 2023 | $-286M | 40.3% (54.8%) | EBITDA | $-221M | Total Liab | $686M | |||||
| 2024 | $59M | 120.5% (113.1%) | Opr Margin | -13.44 | Debt/Equity | - | |||||
| 2025 | $76M | 29.6% (-4.7%) | PreTax Margin | -13.62 | BV/Share | 8 | |||||
| 5Y Average FCF | $-158M | 15.0% (54.4%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.48% | Historical US Bond Yield: | 4.40% | ||||||||
| Discount Rate (WACC): | 12.10% | Current US Bond Yield: | 3.48% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (15.0%) | ||||||||||
| 2026 | $85M | MBG Intrinsic Value | $-15 | ||||||||
| 2027 | $95M | ||||||||||
| 2028 | $105M | ||||||||||
| 2029 | $112M | ||||||||||
| 2030 | $118M | ||||||||||
| 2031 | $121M | ||||||||||
| Terminal Value | $1B | Net Worth/Share | $12 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $1B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $1B | $15 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $0 | WACC | 10.1% | 16 | 17 | 17 | 18 | 18 | |||
| Equity Value | $2B | 11.1% | 15 | 16 | 16 | 16 | 17 | ||||
| Shares Outstanding | 143,215,382 | 12.1% | 15 | 15 | 15 | 15 | 16 | ||||
| 13.0% | 14 | 14 | 14 | 15 | 15 | ||||||
| DCF Intrinsic Value | $15 | 14.0% | 13 | 14 | 14 | 14 | 14 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||